Guardian Pharmacy Services, Inc. (NYSE:GRDN) Director Thomas J. Salentine, Jr. Sells 3,508,905 Shares

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) Director Thomas J. Salentine, Jr. sold 3,508,905 shares of the stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $20.16, for a total transaction of $70,739,524.80. Following the completion of the sale, the director now directly owns 2,591,271 shares in the company, valued at approximately $52,240,023.36. This trade represents a 57.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Guardian Pharmacy Services Stock Up 2.3%

Guardian Pharmacy Services stock traded up $0.49 during mid-day trading on Tuesday, hitting $21.78. 290,686 shares of the company's stock traded hands, compared to its average volume of 169,453. The firm has a 50 day moving average price of $23.18 and a 200 day moving average price of $22.01. Guardian Pharmacy Services, Inc. has a one year low of $14.16 and a one year high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to analysts' expectations of $321.21 million. As a group, research analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Truist Financial reaffirmed a "buy" rating and issued a $28.00 price objective (up previously from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Wall Street Zen downgraded Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Raymond James set a $28.00 target price on Guardian Pharmacy Services and gave the company an "outperform" rating in a research note on Wednesday, May 14th.

Institutional Trading of Guardian Pharmacy Services

Several institutional investors have recently modified their holdings of GRDN. GAMMA Investing LLC bought a new stake in Guardian Pharmacy Services in the first quarter worth about $170,000. R Squared Ltd acquired a new position in shares of Guardian Pharmacy Services in the 4th quarter worth approximately $30,000. BNP Paribas Financial Markets bought a new stake in shares of Guardian Pharmacy Services in the 4th quarter worth approximately $37,000. Compass Financial Services Inc acquired a new stake in Guardian Pharmacy Services during the fourth quarter valued at approximately $58,000. Finally, JPMorgan Chase & Co. bought a new stake in Guardian Pharmacy Services during the fourth quarter worth approximately $77,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.